A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo
Clinical trial NCT06435936 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06435936
- Sponsor
- SAb Biotherapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2025-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.